Perspective Therapeutics, Inc. (CATX) Downgraded to Sector Perform by RBC Capital

Market Context

Perspective Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $1.21 with a market capitalization of $200.3M. The stock has declined 41.0% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow RBC Capital's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Perspective Therapeutics, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 26, 2026	RBC Capital	Sector Perform	N/A
Oct 07, 2026	BTIG	Buy	N/A
Sep 18, 2026	William Blair	Outperform	N/A
Sep 15, 2026	Wedbush	Outperform	N/A
Aug 19, 2026	BMO Capital	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View CATX Stock Page